首页> 外文期刊>Clinical Epidemiology >Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring
【24h】

Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring

机译:孕期孕妇抑郁和抗抑郁药的使用以及后代自闭症谱系障碍的风险

获取原文
           

摘要

Background: Results of some studies suggest that prenatal antidepressant exposure increases the risk of autism spectrum disorder (ASD) in offspring, while other studies suggest that depression independently increases the risk of having a child with ASD. Thus, confounding by indication is a concern. Objective: The aim of this study was to estimate the risk of ASD in offspring of women who were exposed to antidepressants and/or had depression during pregnancy compared to unexposed women. Materials and methods: We conducted a cohort study with nested sibling case–control analysis. Using the UK Clinical Practice Research Datalink (CPRD), we identified mother–baby pairs where the mother had ≥12 months of history before the delivery date and the child had ≥3 years of follow-up. Exposures during pregnancy were classified as 1) depression treated with antidepressants, 2) untreated depression, 3) other indications for antidepressant use, and 4) 4:1 match of unexposed women with no history of depression or antidepressant use. We calculated the prevalence of ASD and relative risk (RR) with 95% CI. In the sibling analysis, we compared exposure among ASD cases to that of non-ASD siblings born to the same mother. We calculated ORs and 95% CIs for women with treated and untreated depression, compared to unexposed. Results: We identified 2,154 offspring with ASD among 194,494 mother–baby pairs. Compared to unexposed, the RR of ASD was 1.72 (95% CI 1.54–1.93) for treated depression and 1.50 (95% CI 1.28–1.75) for untreated depression, while the RR was not elevated in women who received antidepressants for other indications (RR =0.73, 95% CI 0.41–1.29). Additional analyses to assess the effects of severity of depression suggest that the risk of ASD in offspring increases with increasing severity, not with the antidepressant treatment. The results of the sibling analysis were similar to the main analysis. Conclusion: Women with depression during pregnancy have an increased risk of having a child with ASD, regardless of antidepressant use.
机译:背景:一些研究结果表明,产前抗抑郁药暴露会增加后代自闭症谱系障碍(ASD)的风险,而其他研究则表明抑郁症会独立增加生有ASD的风险。因此,通过指示混淆是一个问题。目的:本研究的目的是评估与未暴露的妇女相比,暴露于抗抑郁药和/或在怀孕期间患有抑郁症的妇女的后代发生ASD的风险。材料和方法:我们进行了一项队列研究,其中包括嵌套的兄弟病例对照分析。使用英国临床实践研究数据链(CPRD),我们确定了母婴对,其中母亲在分娩日期之前有≥12个月的病史,并且孩子有≥3年的随访。怀孕期间的暴露分类为:1)用抗抑郁药治疗的抑郁症,2)未经治疗的抑郁症,3)使用抗抑郁药的其他适应症和4)没有接触抑郁症或抗抑郁药史的未暴露女性的4:1匹配。我们计算了95%CI的ASD患病率和相对风险(RR)。在同胞分析中,我们将ASD病例与同一母亲所生的非ASD兄弟姐妹的暴露水平进行了比较。我们计算了患有未治疗和未治疗抑郁症的妇女的OR和95%CI。结果:我们在194,494对母婴中鉴定了2,154例患有ASD的后代。与未暴露相比,治疗后的抑郁症的ASD RR为1.72(95%CI 1.54–1.93),未经治疗的抑郁症为1.50(95%CI 1.28-1.75),而接受抗抑郁药治疗其他适应症的女性的RR并未升高( RR = 0.73,95%CI 0.41-1.29)。评估抑郁症严重程度影响的其他分析表明,后代发生ASD的风险会随着严重程度的增加而增加,而抗抑郁药则不会。同级分析的结果与主要分析相似。结论:怀孕期间患有抑郁症的妇女,无论使用何种抗抑郁药,其患ASD的风险都会增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号